DIAGNOSTIC SCREENING PORTAL

Patient Disease Screening Hub

Select an active disease module below to launch its dedicated clinical screening studio.

Breast Cancer Screening Studio
● READY (v1.0-PROD)
Oncology & Cytopathology

Breast Cancer Screening Studio

Evaluates 8 fine-needle biopsy cellular morphometric biomarkers (cell radius, perimeter, concavity, and texture) using 8-qubit variational quantum circuits and classical ensembles.

Cohort569 Tissue Cases
Validation98.2% Consensus
Open Clinical Studio
Heart Attack & Cardiac ECG Studio
● READY (v1.0-PROD)
Cardiology & Emergency Care

Heart Attack & Cardiac ECG Studio

Evaluates 12-lead paper ECG images for acute myocardial infarction, arrhythmias, and conduction blocks using ResNet-18 (CX-01) and 8-qubit VQC (Transfinite-1) with real-time Grad-CAM pinpointing and cardiac risk scoring.

CohortVerified Clinical Cohort
Validation98.8% Consensus
Open Clinical Studio
Neurological & Brain Health Studio
BETA (LOCKED)
Neurology & Neuro-Electrophysiology

Neurological & Brain Health Studio

Analyzes multi-channel EEG frequency spectrums, cognitive response latency, and neural spike wave anomalies to detect early-stage neurodegenerative disorders.

Cohort400 Neuro Profiles
ValidationUnder Multi-Center Trial

QuantumX Multi-Disease Screening Architecture

How dual-engine classical and variational quantum models evaluate clinical risk

Validated Framework

Simultaneous Dual-Engine Execution

Every screening pass concurrently runs classical ML baseline (CX-01) and an 8-qubit variational quantum classifier (Transfinite-1) on independent pipelines.

Directional SHAP Risk Attribution

Calculates distinct quantum and classical feature impacts so clinicians know which exact cellular or physiological measurements elevated risk.

Physical IBM Quantum Target (Aleph-1)

Built on 127-qubit IBM Eagle superconducting quantum hardware architecture with automated Pauli-Z tensor mapping and readout error mitigation.

Ready to test? Access live diagnostics or explore system benchmarks.